Title : Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer
link : Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer
Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer
Clinical Oncology News
Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer
Washington—Eradication of chronic infection with the hepatitis C virus with the new class of antiviral agents is associated with a 71% reduction in the risk for de novo liver cancer, according to a large retrospective cohort study involving the Veterans Affairs health care system.The findings should provide some assurance for patients taking direct-acting antivirals (DAAs), according to lead study author George Ioannou, BMBCh, MS, the director of hepatology at Veterans Affairs Puget Sound Health Care System, in Seattle.
Continue to article: http://www.clinicaloncology.com/Other-Solid-Tumors/Article/06-18/DAAs-Linked-to-Less-Liver-Cancer/50062
On This Blog
Liver cancer incidence after HCV therapy
This page offers an index of links to current data investigating the possible risk of developing liver cancer (hepatocellular carcinoma, or HCC) during and after direct-acting antiviral therapy in patients with hepatitis C.
Thus Article Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer
That's an article Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer with the link address https://theleknews.blogspot.com/2018/06/study-may-lessen-controversy-over-daas.html
0 Response to "Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer"
Post a Comment